Zong-Sheng Guo (Zong Sheng Guo, Zongsheng Guo, Z Sheng Guo)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Biomedicines

Cancers

Cancer immunology, immunotherapy : CII

Cancer gene therapy

University of Pittsburgh

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh

United States

Faculty :: Surgery

Publications

Junjie Ye, Lingjuan Chen, Julia Waltermire, Jinshun Zhao, Jinghua Ren, Zong-Sheng Guo, David L Bartlett, Zuqiang Liu
Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models. Cancers 16 (5) (2024)
Junjie Ye, Lingjuan Chen, Julia Waltermire, Jinshun Zhao, Jinghua Ren, Zong-Sheng Guo, David L Bartlett, Zuqiang Liu
Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models. Cancers 16 (5) (2024)
Weilin Liu, Hongqi Chen, Zhi Zhu, Zuqiang Liu, Congrong Ma, Yong J Lee, David L Bartlett, Zong-Sheng Guo
Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy. Biomedicines 10 (6) (2022)
Enyong Dai, Zhi Zhu, Shudipto Wahed, Zhaoxia Qu, Walter J Storkus, Zong-Sheng Guo
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Molecular cancer 20 (1) (2021)
Min Yang, Esther Giehl, Chao Feng, Mathilde Feist, Hongqi Chen, Enyong Dai, Zuqiang Liu, Congrong Ma, Roshni Ravindranathan, David L Bartlett, Binfeng Lu, Zong-Sheng Guo
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity. Cancer immunology, immunotherapy : CII 70 (9) (2021)
Zong-Sheng Guo
Oncolytic Virus Immunotherapy: Showcasing Impressive Progress in Special Issue II. Biomedicines 9 (6) (2021)
Zong-Sheng Guo, Michael T Lotze, Zhi Zhu, Walter J Storkus, Xiao-Tong Song
Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy. Biomedicines 8 (7) (2020)
Bingtao Tang, Zong-Sheng Guo, David L Bartlett, David Z Yan, Claire P Schane, Diana L Thomas, Jia Liu, Grant McFadden, Joanna L Shisler, Edward J Roy
Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (9) (2020)
Mathilde Feist, Zhi Zhu, Enyong Dai, Congrong Ma, Zuqiang Liu, Esther Giehl, Roshni Ravindranathan, Stacy J Kowalsky, Natasa Obermajer, Udai S Kammula, Andrew J H Lee, Michael T Lotze, Zong-Sheng Guo, David L Bartlett
Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy. Cancer gene therapy 28 (1-2) (2020)
Zong-Sheng Guo, Binfeng Lu, Zongbi Guo, Esther Giehl, Mathilde Feist, Enyong Dai, Weilin Liu, Walter J Storkus, Yukai He, Zuqiang Liu, David L Bartlett
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics. Journal for immunotherapy of cancer 7 (1) (2019)
Zong-Sheng Guo
The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer). BMC cancer 18 (1) (2018)
Zuqiang Liu, Yan Ge, Haiyan Wang, Congrong Ma, Mathilde Feist, Songguang Ju, Zong-Sheng Guo, David L Bartlett
Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2. Nature communications 9 (1) (2018)
Dae-Hee Lee, Daeho Kim, Sung Tae Kim, Soyeon Jeong, Jung Lim Kim, Sang Mi Shim, Ah Jung Heo, Xinxin Song, Zong-Sheng Guo, David L Bartlett, Sang Cheul Oh, Junho Lee, Yoshiro Saito, Bo Yeon Kim, Yong Tae Kwon, Yong J Lee
PARK7 modulates autophagic proteolysis through binding to the N-terminally arginylated form of the molecular chaperone HSPA5. Autophagy 14 (11) (2018)

Zong-Sheng Guo.css-eqlu8i{font-size:small;padding-left:4px;} (Zong Sheng Guo, Zongsheng Guo, Z Sheng Guo)

Publication Activity (10 Years)

Top Topics

Top Venues

Zong-Sheng Guo (Zong Sheng Guo, Zongsheng Guo, Z Sheng Guo)